Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Laryngology and Otology|October 30, 2010
Isolated itching of external auditory canal: clinicopathological study with immunohistochemical determination of antimicrobial peptidesB Acar, G Güler Simsek, S Oguztuzun, et al.
Journal of the American Mosquito Control Association|March 20, 1999
Cyfluthrin (EW 050)-impregnated bednets in a malaria control program in Ghassreghand (Baluchistan, Iran)M Zaim, M B Ghavami, M Nazari, et al.
Clinical Rheumatology|June 26, 2012
Effect of 12 months treatment with chondroitin sulfate on cartilage volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled pilot study using MRIJ-J Railhac, M Zaim, A-S Saurel, et al.
Acta Tropica|May 27, 2008
Field evaluation of an insect growth regulator, pyriproxyfen 0.5% GR against Culex quinquefasciatus, the vector of Bancroftian filariasis in Pondicherry, IndiaP Jambulingam, C Sadanandane, P S Boopathi Doss, et al.
Methodsx|January 13, 2025
Monitoring air quality index with EWMA and individual charts using XGBoost and SVR residualsZulfani Alfasanah, M Zaim Husnun Niam, Sri Wardiani, et al.
Differentiation; Research in Biological Diversity|July 1, 1993
Tissue-specific and differentiation-appropriate expression of the human involucrin gene in transgenic mice: an abnormal epidermal phenotypeJ F Crish, J M Howard, T M Zaim, et al.
The Malaysian Journal of Pathology|December 28, 2024
Clinical and histopathological evaluation of patients with endometrial cancer in a University Hospital: Seven-year experienceS N M Zaim, S N M Nafi, N Zawawi, et al.
Journal of Colloid and Interface Science|June 30, 2022
Folic acid conjugated PAMAM-modified mesoporous silica-coated superparamagnetic iron oxide nanoparticles for potential cancer therapyT Sagir, M Huysal, M Senel, et al.
Bulletin of the World Health Organization|February 8, 2006
Exploiting the potential of vector control for disease preventionH Townson, M B Nathan, M Zaim, et al.
Clinical and Experimental Rheumatology|July 5, 2011
Comparative efficacy and safety of two different molecular weight (MW) hyaluronans F60027 and Hylan G-F20 in symptomatic osteoarthritis of the knee (KOA). Results of a non inferiority, prospective, randomized, controlled trialE Maheu, M Zaim, T Appelboom, et al.
Pageof 4